Does ABROCITINIB Cause Therapeutic response shortened? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Therapeutic response shortened have been filed in association with ABROCITINIB (CIBINQO). This represents 0.2% of all adverse event reports for ABROCITINIB.
5
Reports of Therapeutic response shortened with ABROCITINIB
0.2%
of all ABROCITINIB reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapeutic response shortened From ABROCITINIB?
Of the 5 reports.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABROCITINIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ABROCITINIB Cause?
Drug ineffective (398)
Condition aggravated (316)
Off label use (269)
Therapeutic product effect incomplete (186)
Pruritus (171)
Rash (134)
Nausea (130)
Dermatitis atopic (110)
Headache (85)
Acne (73)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which ABROCITINIB Alternatives Have Lower Therapeutic response shortened Risk?
ABROCITINIB vs ACALABRUTINIB
ABROCITINIB vs ACAMPROSATE
ABROCITINIB vs ACARBOSE
ABROCITINIB vs ACCUTANE
ABROCITINIB vs ACEBUTOLOL